A Summary of the 2020 Gastric Cancer Summit at Stanford University

This summit brought together academic physicians, researchers, policy leaders, and patient advocates to identify strategies to combat gastric cancer in high-risk US populations through prevention and early detection.

Gastric cancer
Authors

Huang RJ

Koh H

Hwang JH

Abnet CC

Alarid-Escudero F

Amieva MR

Bruce MG

Camargo MC

Chan AT

Choi IJ

Corvalan A

Davis JL

Deapen D

Epplein M

Greenwald DA

Hamashima C

Hur C

Inadomi JM

Ji HP

Jung HY

Lee E

Lin B

Palaniappan LP

Parsonnet J

Peek RM

Piazuelo MB

Rabkin CS

Shah SC

Smith A

So S

Stoffel EM

Umar A

Wilson KT

Woo Y

Yeoh K

Published

July 21, 2020

Recommended citation

Huang RJ, Koh H, Hwang JH, Abnet CC, Alarid-Escudero F, Amieva MR, Bruce MG, Camargo MC, Chan AT, Choi IJ, Corvalan A, Davis JL, Deapen D, Epplein M, Greenwald DA, Hamashima C, Hur C, Inadomi JM, Ji HP, Jung HY, Lee E, Lin B, Palaniappan LP, Parsonnet J, Peek RM, Piazuelo MB, Rabkin CS, Shah SC, Smith A, So S, Stoffel EM, Umar A, Wilson KT, Woo Y, Yeoh K. A Summary of the 2020 Gastric Cancer Summit at Stanford University. Gastroenterology, 2020;159(4):1221-1226.

   

Published in:

 

Abstract

 

There exists no coherent national strategy for the early detection or prevention of gastric cancer in the United States, even among identified high-risk groups such as Asian Americans, African Americans, Hispanic Americans, and Alaska Native/American Indian peoples. As a result, patients with gastric cancer in the United States are diagnosed at later stages and demonstrate worse overall survival compared to nations of East Asia with established screening programs (Table 1). The under-recognition of gastric cancer risk within minority communities is a significant unaddressed health care disparity. South Korean data adapted from the Korea National Cancer Incidence Database. Japanese data derived from the Center from the National Cancer Center of Japan. United States data derived from Surveillance, Epidemiology, and End Results Program (SEER) of the National Cancer Institute. 5-year relative survival rates are presented. Summary stages defined by SEER criteria.

 

To address this disparity, the Division of Gastroenterology and Hepatology and the Center for Asian Health Research and Education at Stanford University hosted the inaugural Gastric Cancer Summit on March 5–6, 2020. This summit brought together academic physicians, researchers, policy leaders, and patient advocates to identify strategies to combat gastric cancer in high-risk US populations through prevention and early detection. The first day of the Summit consisted of health policy- and advocacy-oriented presentations, and the second day consisted of scientific presentations on advances in early detection and prevention.